ScholarWorks@Korea University College of Medicine: Shim, Wan Joo

Detailed Information

Shim, Wan Joo (심완주)

Anam Hospital (Department of Cardiology, Anam Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Atrial fibrillation:13||coronary artery disease:8||Coronary artery disease:8||Echocardiography:7||Acute myocardial infarction:6||atrial fibrillation:5||hypertension:5||Hypertension:5||Women:5||Myocardial infarction:5||diastolic dysfunction:4||myocardial infarction:4||echocardiography:4||Epicardial adipose tissue:3||Left atrium:3||sex:3||Chest pain:3||Left ventricle:3||Strain:3||Dilated cardiomyopathy:3||Hypertrophy:3||Catheter ablation:2||sex difference:2||Remodelling:2||Heart failure:2||stem cells:2||heart failure:2||좌심실 비대환자:2||좌심실비대:2||Cardiovascular disease:2||Diabetes mellitus:2||Percutaneous coronary intervention:2||Rosuvastatin:2||Cardioversion:2||left ventricular:2||Cardiomyopathy:2||Chlamydia pneumoniae:2||Sex:2||chest pain:2||Magnetic resonance imaging:2||Echocardiography.:2||metabolic syndrome:2||young:2||coronary flow reserve:2||Coronary angiogram:2||Metabolic syndrome:2||Electric countershock:2||percutaneous coronary intervention:2||diastolic function:2||Coronary restenosis:2||Left atrial appendage:2||Coronary artery stenosis:2||심근경색:2||Radiofrequency catheter ablation:2||Circardian variation.:1||Clodronate:1||Clompramine에 의해 유발된 만성 확장성 심근증:1||Clopidogrel:1||Complete AV block:1||Complications:1||Congenital left ventricular aneurysm.:1||Contrastenhanced threedimensional rotational angiography (3DRA):1||Coronary blood flow:1||Coronary blood flow velocity:1||Coronary circulation:1||Coronary flow reserve:1||Coronary flow reserve.:1||Coronary flow velocity reserve:1||Coronary heart disease:1||Coronary microvascular function:1||Coronary occlusion:1||Coronary stenosis:1||Coronary vasospasm:1||DDDtype pacemaker:1||DISPERSION:1||Depression:1||Diaphragmatic paralysis:1||Diastole:1||Diastolic:1||Diastolic atrioventricular valve regurgitation:1||Diastolic function:1||Difference:1||Dipyridamole:1||Dipyridamole echocardiography:1||Dobutamine echocardiography:1||Dobutamine stress:1||Dobutamine stress echocardiography:1||Doppler:1||Doxorubicin:1||Drugeluting stent:1||Dyssynchrony:1||ELECTROPHYSIOLOGICAL CHARACTERISTICS:1||EXTRASTIMULI:1||Echocardiographic predictors:1||Echocardiograpy:1||Electrical cardioversion:1||Electrical remodeling:1||Electromechanical conduction time:1||Elevated pulmonary capillary wedge pressure:1||Endothelium:1||Essential hypertension:1||Estrogens:1||Exercise:1||Exercise Electrocardiogram:1||Exercise electrocardiogram:1||Exercise test:1||Exercisestress electrocardiography:1||Fimasartan:1||Fulminant lymphocytic myocarditis:1||GABA:1||Gliburide:1||Global longitudinal strain:1||Granulocytecolony stimulating factor·Bone marrow mononuclear cell·Cardiac remodeling·
Myocardial infarction·Reperfusion:1||HMGCoA:1||Heart Failure:1||Heart Rate:1||Heart block:1||Highsensitivity Creactive protein:1||Hypercholesterolemia:1||Hypertension；Cardiac function tests.:1||INVITRO:1||Immuonglobuli:1||Infective endocarditis:1||Inflammation:1||Integrated backscatter:1||Ischemiareperfusion:1||JT dispersion:1||K[ATP] 통로；활동전위기간；상환현상；부정맥유발.:1||Larginine:1||Lacidipine:1||Layer:1||Left Ventricular Reverse Remodeling:1||Left atrial appendage∙Ostial stenosis.:1||Left atrial function:1||Left bundle branch block:1||Left main disease:1||Left ventricle∙Pseudoaneurysm∙Myocardial infarction:1||Left ventricular outflow tract obstruction:1||Left ventricular remodeling:1||Left ventricular volume:1||Lipoprotein ( a ):1||Lipoprotein(a) Level in Atherosclerotic Vascular Disease:1||Lung cancer:1||MARROW STROMAL CELLS:1||MIDCAB:1||MODEL:1||Macrophages:1||Marital status:1||Membrane potentials:1||Menopause:1||Mitral inflow:1||Mitral valve prolapse；Echocardiography.:1||Molecular Weight:1||Multielectrode basket catheter:1||Myocardial contrast echocardiography:1||Myocardial diseases:1||Myocardial perfusion.:1||Nterminal probrain natriuretic peptide:1||NTproBNP:1||Nitric oxide:1||Oestrogen:1||Orbital myositis:1||Ovariectomy.:1||Overall obesity:1||P19 embryonal carcinoma cells:1||PR segment slope:1||Peripartum cardiomyopathy:1||Platelet activation:1||Postmenopausal women:1||Potassium channel.:1||Premature ventricular complex:1||Prevalence:1||Primary Pulmonary Hypertension:1||Primary angioplasty:1||Propafenone.:1||Pulmonary embolism:1||Pulmonary vein stenosis:1||Pulmonary veno  occlusive disease:1||QT dispersion:1||QT interval:1||Rwave amplitude:1||RATE ADAPTATION:1||REFRACTORINESS:1||Relationship between Twave normalization on exercise and myocardial functional recovery in patients with acute myocardial infarction:1||Remodeling:1||Reperfusion:1||Reperfusion arrhythmia:1||Reserve:1||Resistant hypertension:1||Right septal bypass tract.:1||Right ventricular outflow tract:1||Risk assessment:1||Risk factor:1||Risk factors.:1||Risk stratification:1||Rotation:1||STsegment depression:1||STEADYSTATE:1||Salt:1||Sex characteristics:1||Sex differences:1||Side Population Cells:1||Sinus of Valsalva:1||Smoking:1||Snoring:1||Spasm:1||Stents:1||Strains:1||Stroke:1||Synchrony:1||Systolic time Interval:1||TACHYCARDIA:1||Tachycardia, atrioventricular nodal reentry:1||Takayasu arteritis:1||Telangiectasia, hereditary hemorrhagic:1||Test accuracy:1||Thromboembolism:1||Thrombogenecity:1||Tissue Doppler echocardiography:1||Transthoracic echocardiography (TTE):1||Trastuzumab:1||Treatment of end stage heart failure along the pathophysiogy and reverse remodeling.:1||Twist:1||Urokinase:1||VENTRICULARFIBRILLATION:1||VULNERABILITY:1||Vasopressin:1||Vasospasm:1||Ventricular fibrillation:1||Ventricular remodeling:1||Ventricular tachycardia:1||Visceral fat:1||Visceral obesity:1||Woman:1||a:1||acute myocardial infarction:1||aldosterone:1||angina pectoris:1||angiotensin II:1||angiotensin receptor blocker:1||antihypertensive agents:1||antioxidant:1||aortic stiffness:1||artificial·Endocarditis.:1||aza compounds:1||betablocker:1||blood pressure measurements:1||bone marrow:1||bone morphogenetic proteins:1||cDNA microarray:1||calcium channel blocker:1||carcinoma cells:1||cardiac function:1||cardiac myocytes, cell differentiation:1||cardiac risk factors and prevention:1||cardiomyogenic differentiation:1||cardiomyopathy:1||cardiovascular death:1||cardioversion:1||carotid intimamedia thickness:1||carotid strain:1||catheter ablation:1||cell differentiation:1||cell transplantation:1||circulation, coronary:1||cold stimulation:1||coronary angiography:1||coronary blood flow velocity:1||coronary pseudoaneurysm:1||coronary vasodilatory reserve:1||coronary vasospasm:1||covered stent:1||dimethyl sulphoxide:1||drugeluting stent:1||dual promoters:1||dyslipidemia:1||embolism:1||embryoid body:1||endothelial cell differentiation:1||endothelial differentiation:1||epicardial ablation:1||fixeddose combination therapy:1||gene expression:1||gene expression profile:1||heart:1||heart failure with preserved ejection fraction:1||heart volume:1||hypertrophy:1||icrovascular stunning:1||infarction:1||inferior vena cava:1||isolated ventricular noncompaction:1||left atrial appendage flow velocity:1||left ventricle:1||left ventricular dyssynchrony:1||left ventricular function:1||left ventricular hypertrophy:1||left ventricular systolic dysfunction:1||left ventricular；Electrocardiogram；Left ventricular mass；Echocardiogram.:1||malondialdehyde:1||malondialdehyde to oxidative stress:1||mesenchymal stem cells:1||metaanalysis:1||microvascular function:1||minimally invasive direct coronary artery bypass:1||myocardial contrast echocardiography:1||myocardial fibrosis:1||myocardial strain:1||olmesartan medoxomil:1||oxidative stress:1||parity:1||polytetrafluoroethylene:1||pregnancy:1||quality and outcomes of care:1||recurrence:1||regional blood flow:1||renal function:1||reporter genes:1||restenosis:1||revascularization:1||risk factor:1||rosuvastatin:1||safety:1||smoking:1||spontaneous echo contast:1||statin:1||stenting:1||stents:1||strain:1||strain rate imaging:1||target organ damage:1||telmisartan:1||thrombolysis:1||thrombosis:1||tissue Doppler:1||tissue Doppler image:1||transesophageal·Pacemaker:1||transplantation:1||transthoracic Doppler echocardiography:1||trauma:1||twodimensional speckle tracking echocardiography:1||ultrasonography, Doppler:1||valsartan:1||variant:1||vascular endothelial growth factor:1||ventricular septum:1||ventricular tachycardia:1||viability:1||women:1||고혈압·경동맥 내막중막 두께·좌심실비대.:1||고혈압；심기능검사.:1||고혈압성 망막증:1||관동맥:1||관동맥내 Stent 삽입술시:1||관동맥혈류:1||관상동맥혈류속도·관상동맥 혈류예비력.:1||급성 심근경색:1||급성 심근경색환자에서 재관류 후 운동부하 심전도에서 T파의 정상화 소견과 심근기능 회복과의 관계:1||급성심근경색:1||급성심근경색증:1||급성심근경색환자:1||난소 제거된 백서에서 부갑성선 호르몬이:1||다전극 basket도자:1||동맥경화증；Bcl2 유전자.:1||만성:1||발작성 심방세동:1||승모판 일탈증；심초음파.:1||심근관류:1||심방세동:1||심방세동；심방기외수축；구조활성화 관계.:1||심방조동:1||심실중격:1||우상대정맥:1||일차관동맥 스텐트 삽입술:1||장기간:1||재관류:1||저산소성 폐질환:1||젊은 연령의 심근경색증 환자에서 Homocysteine의 영향:1||좌심실비대；심전도；좌심실질량；심초음파.:1||좌심실비대에 미치는 영향:1||토끼 장골동맥에 유도철선 삽입 후 발현된 혈관재구도의 양상:1||허혈성 심질환에서 관동맥 조영술상의:1||허혈후 심근기절:1||혈류예비능:1||혈역학적 반응의 비교연구:1||A case of absent superior vena cava.:1||흰쥐에서 허혈조건 부여가 허혈 후:1||AF = Atrial fibrillation:1||AMI:1||ATP sensitive potassium channel；Action potential duration；Restitution；Proarrhythmia.:1||Accuracy:1||Acute coronary syndrome:1||Adenosine:1||Adipose tissue:1||Adult congenital cardiac disease:1||Ambulatory blood pressure:1||Amiodarone에 의해 각막색소 침착증 1예:1||Anatomy:1||Angina:1||Angina Pectoris:1||Angina pectoris:1||Angioplasty:1||Anthracycline cardiomyopathy:1||Aortic dissection:1||Aortic stenosis:1||Apical ballooning syndrome:1||ApoE Knockout Mouse:1||Arrhythmia:1||Assessment fo coronary flow reserve with transthoracic Doppler echocardiography:1||Atherosclerosis；Bcl2 genes:1||Atorvastatin:1||Atrial fibrillation recurrence:1||Atrial fibrillation；Atrial premature complexes；Structureactivity relationship.:1||Atrial mechanical function:1||Atrial pressure:1||Atrial remodeling:1||Awareness:1||BMP2/FGF4:1||BP variability:1||Balloon angioplasty:1||Beta Blocker:1||Bisoprolol:1||Bleeding:1||Bone Marrow:1||Ca++ blocker:1||Candesartan:1||Cardiac computed tomography (CCT):1||Cardiac function:1||Cardiac mass:1||Cardiac metastasis:1||Cardiac sarcoma . Pericardial tamponade.:1||Cardiomyogenic Differentiation:1||Cardiotoxicity:1||Carotid intimamedia thickness·Hypertension·Left ventricular hypertrophy.:1||Carotid stenosis Carotid intima media thickness:1||Celiprolol.:1||Central obesity:1||Cerebral infarction:1||Changes of Mitral and PulmonicVenous Flow Velocity During Dipyridamole Induced Myocardial Ischemia:1||Chemotherapy:1||

STATISTICS: Total View :13,970,393; Today View :18,548

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE